The short answer
AML is not described by stage I to IV. Doctors look at chromosome changes and gene variants in the leukemia cells to judge outlook and plan treatment. Ask your team which results you have and what they mean for you.
NCI says cytogenetic and molecular analyses give the strongest prognostic information available in AML.
t(8;21), an NPM1 variant without FLT3-ITD, and variants in both copies of CEBPA are linked to a better outlook.
RUNX1 variants, a KIT variant, and a high white blood cell count are linked to a worse outlook.
About 60% to 70% of adults with AML reach remission after induction therapy, and more than 25% survive 3 or more years and may be cured.
On this page
Choose how you want to read this
The whole article, with every detail and caution.
This page is for people with AML who have been told about their genetic results or risk group. It explains what the testing looks at and what NCI says about outlook.
Why AML has no stage number
A stage usually answers two questions: how big, and how far. Those do not fit AML well, because it starts in the blood and bone marrow. So doctors look at the genetics of the leukemia cells themselves. NCI says cytogenetic and molecular analyses provide the strongest prognostic information available.
Teams often sort these results into better, in-between, and worse outlook. Ask your team which group they place you in and which result decided it.
What the testing looks at
Cytogenetics looks at whole chromosomes. A karyotype is the full picture of a cell's chromosomes. It can find pieces that are missing, doubled, flipped, or swapped. Notation like t(8;21) means a translocation, an exchange of material between chromosomes 8 and 21. inv(16) means part of chromosome 16 is flipped.
Molecular testing looks at single genes, such as NPM1, FLT3, CEBPA, RUNX1, and KIT.
Both sets of results usually appear on the pathology report. Our page on AML pathology and molecular results walks through reading that report.
Results linked to a better outlook
NCI's AML treatment summary says:
- AML with t(8;21) is called core binding factor AML. It is linked to long-term survival when treated with high-dose cytarabine.
- An NPM1 variant gives a better outlook when no FLT3-ITD variant is present. That is why both genes are tested together.
- CEBPA variants in both copies of the gene (biallelic) are independently linked to a favorable outlook. Outcomes are described as similar to core binding factor leukemias.
Results linked to a worse outlook
NCI says:
- A white blood cell count above 25 x 10^9/L is linked to a worse outcome, as is a KIT variant.
- RUNX1 variants are linked to a high risk of treatment failure.
NCI also notes other abnormalities linked to poor prognosis. Your team can tell you which, if any, apply to you.
What outlook looks like overall
NCI says about 60% to 70% of adults with AML can expect to reach complete remission after appropriate induction therapy. More than 25% of adults with AML (about 45% of those who reach remission) can expect to survive 3 or more years and may be cured. These are group figures. They do not predict any one person's course.
Transplant
An allogeneic stem cell transplant uses cells from a donor. NCI describes a meta-analysis of 18 prospective trials that compared donor and no-donor approaches in adults aged 60 and younger, enrolled from 1982 to 2006. We could not confirm the detailed results by risk group in the text we opened, so we do not quote them here.
Whether and when to have a transplant is a team decision. It depends on your genetics, age, other health conditions, and how the leukemia responds to treatment. Our page on stem cell transplant covers what the procedure involves.
What a risk group is not
Groups summarize how large numbers of past patients fared. They are a planning tool, not a verdict on any one person. Two people with similar results can end up with different, equally reasonable plans.
Sources
Checked on 2026-10-02:
- National Cancer Institute, Acute Myeloid Leukemia Treatment (PDQ) - Health Professional Version
Common questions
Why isn't AML staged like breast or colon cancer?
Solid tumor stages describe size and spread. AML is a cancer of the blood and bone marrow, so that does not fit. Doctors look at the genetics of the leukemia cells instead. NCI says cytogenetic and molecular analyses give the strongest prognostic information available.
What is cytogenetics?
Cytogenetics is the study of chromosomes, the structures inside cells that carry DNA. A cytogenetic test examines blood or bone marrow for broken, missing, rearranged, or extra chromosomes.
Which results suggest a better outlook?
NCI says AML with t(8;21), called core binding factor AML, is linked to long-term survival with high-dose cytarabine. An NPM1 variant improves outlook when FLT3-ITD is absent. CEBPA variants in both copies are linked to a favorable outlook.
Which results suggest a worse outlook?
NCI says a white blood cell count above 25 x 10^9/L and a KIT variant are linked to a worse outcome. RUNX1 variants are linked to a high risk of treatment failure. Your team can explain which of your results matter most.
Does the risk group decide whether I need a transplant?
It is one factor. Your team also weighs your age, other health conditions and how the leukemia responds to treatment. Ask whether a transplant is being considered, and why.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Talk with a trained specialist or navigator
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Fever of 100.4°F (38°C) or higher during chemo, severe pain, or trouble breathing: call your cancer care team right away, day or night. Call 911 for an emergency.
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Last updated: 2026-10-02Next planned review: 2027-08-03
Review details and limits
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and then compared with the sources listed on it, looking for statements those sources do not back up. That check is not a sentence-by-sentence record and can miss errors. It is not a medical review, and it does not confirm the page is complete or right for your situation.
General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Words to know
Tap any term to see what it means.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and then compared with the sources listed on it, looking for statements those sources do not back up. That check is not a sentence-by-sentence record and can miss errors. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.